The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
289 - For a branded patient education brochures focused on disease/symptom management with only general (drug class-based, non-promotional) mentions of treatment, would disease-related information sourced from a national non-profit patient association be acceptable?
-
I suspect there is a typo in your question. A branded patient piece may not discuss the broader product class or other product classes/therapies. Branded patient information is supposed to educated simply about the prescribed product and the medical condition. With that said, in either a proper branded or unbranded patient piece, a standard setting organization (e.g. the source described in your question) could be considered provided the content complies with the other code sections (e.g. s3.1).
